• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Women-Led Fertility Startup Lushi Launches to Transform the IVF Experience

by Jasmine Pennic 12/11/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Lushi, a new women-led fertility startup, is transforming American women’s IVF and conception experience. 

– Launching in December 2024, Lushi offers personalized treatments, clinics, and wellness platforms tailored to the unique needs of women facing fertility challenges.

Addressing the Growing Need for Fertility Support

Millions of women in the U.S. struggle with infertility, often navigating an antiquated and male-dominated healthcare system. Lushi aims to address this gap by providing accessible, supportive, and empowering solutions for women on their fertility journey. Starting December 10th,  women can use Lushi to hire injection specialists to administer fertility shots, use remote monitoring to support them throughout and give them access to ‘My Fertility Plan,’ a 12-week personalized guide that includes a nutrition plan, step-by-step instructions for egg freezing, and a post-treatment weight loss plan. Lushi offers at-home injection specialists in New York, Los Angeles, Austin, Chicago, and Boston. 

Expanding Services in 2025

Lushi plans to further enhance its offerings in 2025 with:

  • Fertility Wellness Pop-Up Spas: Provides a calming environment with on-site injections, fertility-optimizing mocktails, and yoga sessions.
  • Flagship Injection Bar: Offers a dedicated space for comfortable and convenient fertility injections.
  • Mental Health Support: Integrates mental health services to address the emotional challenges of fertility treatment.

“There is a fertility crisis in this country that translates into a very personal question for millions of American women every day,” said Lushi CEO, Founder, and Point72 alum, Jessica Schaefer. 

“We believe every woman should have the option to build a family when they want to, but the hoops women have to jump through to have a child are not only a burden, but dehumanizing. Lushi – a company led by women like me, someone with first-hand knowledge of this — is going to help solve that problem by making it more humane and easier.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |